Loomis, Sayles & Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-377,835
Closed -$26.1M 725
2024
Q1
$26.1M Sell
377,835
-1,788
-0.5% -$113K 0.04% 225
2023
Q4
$28.1M Sell
379,623
-1,729
-0.5% -$113K 0.04% 213
2023
Q3
$26M Buy
381,352
+65,675
+21% +$5.57M 0.04% 206
2023
Q2
$29.6M Buy
315,677
+314,743
+33,698% +$24.6M 0.05% 191
2023
Q1
$63K Buy
934
+408
+78% +$26.2K ﹤0.01% 589
2022
Q4
$26K Buy
+526
New +$21.5K ﹤0.01% 711
2021
Q1
Sell
-90
Closed -$12K 853
2020
Q4
$12K Buy
+90
New +$10.9K ﹤0.01% 692
2014
Q4
Sell
-767,358
Closed -$14.9M 738
2014
Q3
$14.9M Sell
767,358
-513,564
-40% -$9.42M 0.04% 415
2014
Q2
$21.8M Sell
1,280,922
-43,979
-3% -$606K 0.06% 320
2014
Q1
$18.8M Sell
1,324,901
-8,929
-0.7% -$121K 0.05% 373
2013
Q4
$15.6M Sell
1,333,830
-10,548
-0.8% -$121K 0.05% 423
2013
Q3
$15.9M Buy
1,344,378
+253,488
+23% +$3.25M 0.05% 412
2013
Q2
$15.2K Buy
+1,090,890
New +$11.9M 0.05% 380

Other funds holding EXAS

Loomis, Sayles & Company's EXAS Position: Q2 2024 in Review

Loomis, Sayles & Company sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 377,835 shares — an estimated $26.1M sold.

Loomis, Sayles & Company first reported a position in EXAS in Q2 2013 and held it in 13 quarters. The position peaked at $29.6M in Q2 2023. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Loomis, Sayles & Company reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 377,835 Exact Sciences shares in Q2 2024, an estimated $26.1M.
  • Loomis, Sayles & Company first reported a position in Exact Sciences in Q2 2013 and held it in 13 quarters.
  • Loomis, Sayles & Company's Exact Sciences position peaked at $29.6M in Q2 2023.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Loomis, Sayles & Company's 13F filing for Q2 2024, filed 13 Aug 2024.